ITGR · Integer Holdings Corporation
$98.62
+0.99% last session
End-of-day data · updated 2026-07-28
Market cap
$3B
Enterprise value
$5B
Trailing P/E
24.7
Forward P/E
14.6
Dividend yield
—
Beta
0.64
Avg volume
1M
Employees
11K
2D change
—
5D change
1.95%
10D change
4.17%
30D change
5.87%
60D change
11.21%
MTD change
5.11%
YTD change
26.74%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — ITGR
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-22
Latest call per bank · past 12 months
Citigroup
Neutral$96.00
-2.7% vs priceWells Fargo
Equal-Weight$84.00
-14.8% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-22 | Freedom Capital Markets | Initiates | Buy | $0.00 → $112 |
| 2026-07-16 | Truist Securities | Maintains | Buy | $97.00 → $110 |
| 2026-07-08 | Citigroup | Maintains | Neutral | $92.00 → $96.00 |
| 2026-05-28 | Citigroup | Maintains | Neutral | $89.00 → $92.00 |
| 2026-05-13 | Oppenheimer | Upgrade | Perform → Outperform | $0.00 → $115 |
| 2026-05-01 | Citigroup | Maintains | Neutral | $92.00 → $89.00 |
| 2026-05-01 | Piper Sandler | Reiterates | Overweight | $87.00 → $97.00 |
| 2026-02-20 | Citigroup | Maintains | Neutral | $75.00 → $92.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 64 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 8.4% above the 50-day MA ($92.56).
- Price vs 200-day MA: Trading 18.1% above the 200-day MA ($84.98).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is positive (+0.42) — short-term momentum is improving.
- 52-week range: Price sits between the 52-week low ($63.32) and high ($110.58).
ITGR Price Chart
Loading chart for ITGR…
Fundamentals
About Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
More in Medical Devices
ABT
Abbott Laboratories
$182B -15.0% YTD
SYK
Stryker Corporation
$129B -3.7% YTD
MDT
Medtronic plc.
$108B -10.8% YTD
BSX
Boston Scientific Corporation
$68B -52.3% YTD
EW
Edwards Lifesciences Corporatio
$48B -2.6% YTD
GEHC
GE HealthCare Technologies Inc.
$28B -25.4% YTD
DXCM
DexCom, Inc.
$28B 10.5% YTD
PHG
Koninklijke Philips N.V. NY Reg
$24B -4.0% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.